News
23 Jul 2019
NTC news: Post-cataract surgery
Last June, in Milan, NTC held a very important Investigators’ Meeting of two pivotal registration studies for a novel drug indicated in post cataract surgery: over 50 centers were involved in such large clinical effort and attended the event.
NTC is fostering antibiotic culture in an environment largely impacted by antibiotic resistance, promoting innovation and creating new therapeutic solutions available on worldwide scale.
NTC‘s products are supported by significant evidence based medicine leveraging large randomized clinical trials.
Mentioned Companies
NTC S.r.l.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance